Kaleido Biosciences Inc Asset Turnover Ratio (KLDO), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kaleido Biosciences Inc   (NASDAQ: KLDO)
 

Kaleido Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kaleido Biosciences Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the fourth quarter (Dec 31 2021)

Within sector 84 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 4467 to 4512.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KLDO Asset Turnover Ratio (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Asset Change -16.1 % -0.28 % -3.17 % 59.4 % -28.54 %
Y / Y Revenue Change 102.47 % -78.42 % -15.6 % - -
Asset Turnover Ratio (TTM) 0.01 0.01 0.02 0.02 0.01
KLDO's Total Ranking # 4512 # 4467 # 3925 # 0 #
Seq. Asset Change -32.22 % -13.81 % -20.16 % 79.89 % -19.44 %
Seq. Revenue Change 373.08 % -50.71 % -28.96 % 22.22 % -49.59 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 85
Healthcare Sector # 684
Overall Market # 4512

Asset Turnover Ratio Statistics
High Average Low
0.02 0.01 0.01
(Mar 31 2021)   (Dec 31 2021)




KLDO Company Profile • Back to KLDO Efficiency Comparisons • Compare KLDO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Nurix Therapeutics Inc   0.06 $ 29.750  Millions$ 471.122  Millions
Adc Therapeutics Sa  0.06 $ 33.917  Millions$ 545.511  Millions
Capforce Inc   0.06 $ 4.306  Millions$ 69.418  Millions
Curis Inc   0.06 $ 10.649  Millions$ 176.543  Millions
Xbiotech Inc   0.06 $ 18.394  Millions$ 316.148  Millions
Scholar Rock Holding Corp  0.06 $ 18.816  Millions$ 323.868  Millions
Regenerx Biopharmaceuticals inc   0.06 $ 0.077  Millions$ 1.326  Millions
Kala Bio inc   0.06 $ 11.240  Millions$ 194.633  Millions
Navidea Biopharmaceuticals Inc   0.06 $ 0.532  Millions$ 9.241  Millions
Quantum Cyber N v   0.06 $ 0.577  Millions$ 10.041  Millions
Molecular Partners Ag  0.06 $ 9.754  Millions$ 172.668  Millions
Fate Therapeutics Inc   0.06 $ 55.846  Millions$ 991.914  Millions
Sigilon Therapeutics Inc   0.06 $ 9.599  Millions$ 174.418  Millions
Ardelyx inc   0.05 $ 10.097  Millions$ 184.009  Millions
Avricore Health Inc   0.05 $ 0.094  Millions$ 1.748  Millions
Biocardia Inc   0.05 $ 1.015  Millions$ 19.144  Millions
Inhibrx Biosciences Inc   0.05 $ 7.231  Millions$ 136.505  Millions
Solid Biosciences Inc   0.05 $ 13.620  Millions$ 258.126  Millions
Xenon Pharmaceuticals Inc   0.05 $ 18.437  Millions$ 350.436  Millions
Cyclerion Therapeutics Inc   0.05 $ 3.942  Millions$ 75.693  Millions
Serina Therapeutics Inc   0.05 $ 0.144  Millions$ 2.821  Millions
Beam Therapeutics Inc   0.05 $ 51.844  Millions$ 1,054.332  Millions
Bionano Genomics Inc   0.05 $ 17.981  Millions$ 369.607  Millions
Compugen Ltd  0.05 $ 6.000  Millions$ 132.163  Millions
Morphic Holding inc   0.04 $ 19.794  Millions$ 440.976  Millions
Biodexa Pharmaceuticals Plc  0.04 $ 0.578  Millions$ 12.913  Millions
Dermtech Inc   0.04 $ 11.838  Millions$ 264.735  Millions
Solana Company  0.04 $ 0.522  Millions$ 11.841  Millions
Orphazyme A  0.04 $ 36.193  Millions$ 822.493  Millions
Novan Inc   0.04 $ 2.958  Millions$ 67.387  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.